- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00909493
Chronic Pain Care Network (NSCPCCN)
Nova Scotia Chronic Pain Collaborative Care Network: A Pilot Study
Studieoversikt
Detaljert beskrivelse
Chronic pain is recognized as a world-wide problem. Gureje et al (1) demonstrated that 21% of patients presenting for primary care reported persistent pain and were four times more likely to have a depressive disorder than those without pain. One third of patients with persistent pain had a moderate to severe work role impairment (1). Canadian studies have demonstrated that up to 30% of the population suffers from chronic pain (2, 3). By extrapolation it may be expected that between 20-30% of persons living in Nova Scotia suffer from chronic pain.
Chronic pain is associated with significant morbidity and mortality. It is also associated with increased rates of depression, poorer self related health and increased risk of suicidality (2-4). Poor self-rated health has been demonstrated to be a predictor of increased morbidity and mortality (5-7). Tang and Crane (4) demonstrated that persons with chronic pain have a risk of death by suicide twice that of controls and that the lifetime prevalence of suicide attempts was 5-14%. Chronic pain impairs sleep (8) and may be related to abnormal immune function (9-11). As well, there is morbidity and mortality associated with medications used in the treatment of chronic pain. Although opiate medications form a significant part of the pain management armamentarium they are also associated with serious morbidity including sedation, respiratory depression, death and addiction. Death rates from these medications have risen dramatically (12) in recent years. Ives et al (13) report a 32% incidence of opiate misuse in an academic pain management unit. Cicero et al (14) reported that prescription opiate misuse is more common in rural, suburban and small urban areas, similar to the geographic background of Nova Scotia, and concluded that regionally specific risk minimization strategies should be developed.
The proposed Nova Scotia Chronic Pain Collaborative Care Network (NSCPCCN) is a professional development partnership between family physicians and chronic pain and addiction specialists designed to build capacity in the health care system and provide improved pain management to patients. The NSCPCCN will provide community physicians with access to chronic pain and addiction specialists to assist in the management of patients with chronic pain. The current project is designed as a pilot project to determine the feasibility of this program on a large scale. In order to determine the effect of implementation of a mentor- mentee network in the primary care setting, a pilot project will be undertaken to determine the feasibility and logistics of the NSCPCCN.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Primary Care Physicians in Nova Scotia DHA 1
Exclusion Criteria:
- Primary Care Physicians outside of Nova Scotia DHA 1
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Access to Pain Specialist
Network
|
Primary Care Physicians in this treatment group will have access to a pain specialist at the Pain Management Unit.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The primary outcome for patients will be an improvement in self-rated health.
Tidsramme: 9 months
|
9 months
|
|
The primary outcome for physicians will be an improvement in satisfaction in ability to manage chronic pain conditions.
Tidsramme: 9 months
|
9 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CDHA-RS/2008-006
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .